Citigroup’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Sell
2,257
-3,145
-58% -$483K ﹤0.01% 3723
2025
Q4
$741K Sell
5,402
-1,383
-20% -$179K ﹤0.01% 3331
2025
Q3
$824K Sell
6,785
-6,233
-48% -$672K ﹤0.01% 3287
2025
Q2
$1.39M Sell
13,018
-6,598
-34% -$659K ﹤0.01% 2964
2025
Q1
$1.82M Buy
19,616
+187
+1% +$18.1K ﹤0.01% 2783
2024
Q4
$2.09M Buy
19,429
+1,939
+11% +$236K ﹤0.01% 2782
2024
Q3
$2.2M Buy
17,490
+5,411
+45% +$680K ﹤0.01% 2582
2024
Q2
$1.31M Buy
12,079
+802
+7% +$78.2K ﹤0.01% 2701
2024
Q1
$1.07M Sell
11,277
-3,193
-22% -$302K ﹤0.01% 2969
2023
Q4
$1.34M Buy
14,470
+10,164
+236% +$779K ﹤0.01% 2588
2023
Q3
$275K Sell
4,306
-4,932
-53% -$316K ﹤0.01% 3466
2023
Q2
$571K Buy
9,238
+5,211
+129% +$309K ﹤0.01% 3280
2023
Q1
$234K Buy
4,027
+1,569
+64% +$90.2K ﹤0.01% 3648
2022
Q4
$146K Buy
2,458
+463
+23% +$28.1K ﹤0.01% 3866
2022
Q3
$127K Sell
1,995
-824
-29% -$57.2K ﹤0.01% 3986
2022
Q2
$197K Buy
2,819
+180
+7% +$12.6K ﹤0.01% 3862
2022
Q1
$185K Sell
2,639
-3,417
-56% -$230K ﹤0.01% 4119
2021
Q4
$411K Buy
6,056
+1,794
+42% +$124K ﹤0.01% 3923
2021
Q3
$298K Sell
4,262
-1,807
-30% -$131K ﹤0.01% 3921
2021
Q2
$424K Buy
6,069
+211
+4% +$15.3K ﹤0.01% 3807
2021
Q1
$456K Sell
5,858
-1,495
-20% -$106K ﹤0.01% 3522
2020
Q4
$488K Buy
7,353
+1,956
+36% +$129K ﹤0.01% 4230
2020
Q3
$336K Buy
5,397
+1,172
+28% +$73.3K ﹤0.01% 4200
2020
Q2
$268K Sell
4,225
-1,712
-29% -$115K ﹤0.01% 4792
2020
Q1
$426K Buy
5,937
+2,811
+90% +$222K ﹤0.01% 4018
2019
Q4
$270K Sell
3,126
-1,522
-33% -$127K ﹤0.01% 4934
2019
Q3
$380K Sell
4,648
-588
-11% -$48.7K ﹤0.01% 4599
2019
Q2
$425K Buy
5,236
+893
+21% +$68.9K ﹤0.01% 4580
2019
Q1
$330K Sell
4,343
-28
-0.6% -$2.22K ﹤0.01% 4613
2018
Q4
$343K Buy
4,371
+727
+20% +$56.9K ﹤0.01% 4510
2018
Q3
$274K Sell
3,644
-1,430
-28% -$105K ﹤0.01% 4922
2018
Q2
$357K Sell
5,074
-13,065
-72% -$855K ﹤0.01% 4443
2018
Q1
$1.08M Buy
18,139
+1,292
+8% +$79.2K ﹤0.01% 3169
2017
Q4
$1.03M Buy
16,847
+1,963
+13% +$125K ﹤0.01% 3315
2017
Q3
$932K Buy
14,884
+1,918
+15% +$124K ﹤0.01% 3454
2017
Q2
$909K Buy
12,966
+5,686
+78% +$406K ﹤0.01% 3420
2017
Q1
$519K Sell
7,280
-10,424
-59% -$771K ﹤0.01% 3840
2016
Q4
$1.34M Buy
17,704
+5
+0% +$346 ﹤0.01% 3395
2016
Q3
$1.17M Buy
17,699
+12,131
+218% +$787K ﹤0.01% 3058
2016
Q2
$361K Sell
5,568
-3,166
-36% -$201K ﹤0.01% 3971
2016
Q1
$544K Buy
8,734
+4,766
+120% +$297K ﹤0.01% 4031
2015
Q4
$245K Buy
3,968
+3,666
+1,214% +$238K ﹤0.01% 4551
2015
Q3
$18K Sell
302
-1,019
-77% -$63.8K ﹤0.01% 6103
2015
Q2
$86K Sell
1,321
-2,461
-65% -$156K ﹤0.01% 5121
2015
Q1
$241K Sell
3,782
-2,623
-41% -$167K ﹤0.01% 4356
2014
Q4
$403K Buy
6,405
+4,724
+281% +$284K ﹤0.01% 4087
2014
Q3
$93K Sell
1,681
-8,779
-84% -$496K ﹤0.01% 4828
2014
Q2
$589K Buy
10,460
+4,491
+75% +$245K ﹤0.01% 3343
2014
Q1
$332K Sell
5,969
-1,707
-22% -$89.5K ﹤0.01% 3860
2013
Q4
$414K Buy
7,676
+4,926
+179% +$252K ﹤0.01% 3976
2013
Q3
$130K Sell
2,750
-2,714
-50% -$130K ﹤0.01% 4515
2013
Q2
$261K Buy
+5,464
New +$255K ﹤0.01% 4054

Other funds holding NHC

Citigroup's NHC Position: Q1 2026 in Review

Citigroup reduced its National Healthcare (NHC) stake by 58% in Q1 2026, selling an estimated $483K and leaving 2,257 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

Citigroup first reported a position in NHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.2M in Q3 2024. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Citigroup held 2,257 shares of National Healthcare worth $360K as of Q1 2026.
  • Citigroup sold 3,145 National Healthcare shares in Q1 2026, an estimated $483K.
  • National Healthcare made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3723 holding.
  • Citigroup first reported a position in National Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's National Healthcare position peaked at $2.2M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.